Gebru Niat T, Guergues Jennifer, Verdina Laura A, Wohlfahrt Jessica, Wang Shuai, Armendariz Debra S, Gray Marsilla, Beaulieu-Abdelahad David, Stevens Stanley M, Gulick Danielle, Blair Laura J
Byrd Alzheimer's Center and Research Institute, Tampa, Florida, USA.
Department of Molecular Medicine, University of South Florida, Tampa, Florida, USA.
Aging Cell. 2024 Dec;23(12):e14314. doi: 10.1111/acel.14314. Epub 2024 Sep 3.
FKBP51, also known as FK506-binding protein 51, is a molecular chaperone and scaffolding protein with significant roles in regulating hormone signaling and responding to stress. Genetic variants in FKBP5, which encodes FKBP51, have been implicated in a growing number of neuropsychiatric disorders, which has spurred efforts to target FKBP51 therapeutically. However, the molecular mechanisms and sub-anatomical regions influenced by FKBP51 in these disorders are not fully understood. In this study, we aimed to examine the impact of Fkbp5 ablation using circadian phenotyping and molecular analyses. Our findings revealed that the lack of FKBP51 did not significantly alter circadian rhythms, as detected by wheel-running activity, but did offer protection against stress-mediated disruptions in rhythmicity in a sex-dependent manner. Protein changes in Fkbp5 KO mice, as measured by histology and proteomics, revealed alterations in a brain region- and sex-dependent manner. Notably, regardless of sex, aged Fkbp5 KOs showed elevated MYCBP2, FBXO45, and SPRYD3 levels, which are associated with neuronal-cell adhesion and synaptic integrity. Additionally, pathways such as serotonin receptor signaling and S100 family signaling were differentially regulated in Fkbp5 KO mice. Weighted protein correlation network analysis identified protein networks linked with synaptic transmission and neuroinflammation. The information generated by this work can be used to better understand the molecular changes in the brain during aging and in the absence of Fkbp5, which has implications for the continued development of FKBP51-focused therapeutics for stress-related disorders.
FKBP51,也被称为FK506结合蛋白51,是一种分子伴侣和支架蛋白,在调节激素信号传导和应对压力方面发挥着重要作用。编码FKBP51的FKBP5基因变异与越来越多的神经精神疾病有关,这促使人们努力将FKBP51作为治疗靶点。然而,在这些疾病中,FKBP51影响的分子机制和亚解剖区域尚未完全了解。在本研究中,我们旨在通过昼夜节律表型分析和分子分析来研究Fkbp5基因敲除的影响。我们的研究结果表明,通过转轮活动检测,缺乏FKBP51并没有显著改变昼夜节律,但确实以性别依赖的方式为抵抗压力介导的节律紊乱提供了保护。通过组织学和蛋白质组学测量,Fkbp5基因敲除小鼠的蛋白质变化显示出脑区和性别依赖的改变。值得注意的是,无论性别如何,老年Fkbp5基因敲除小鼠的MYCBP2、FBXO45和SPRYD3水平升高,这些与神经元细胞粘附和突触完整性有关。此外,Fkbp5基因敲除小鼠中血清素受体信号传导和S100家族信号传导等通路受到不同程度的调节。加权蛋白质相关网络分析确定了与突触传递和神经炎症相关的蛋白质网络。这项工作产生的信息可用于更好地理解衰老过程中以及缺乏Fkbp5时大脑中的分子变化,这对继续开发针对应激相关疾病的以FKBP51为重点的治疗方法具有重要意义。